DE69426771T2 - Dopaminreinkorporationshemmer zur behandlung des parkinsonschen syndroms - Google Patents

Dopaminreinkorporationshemmer zur behandlung des parkinsonschen syndroms

Info

Publication number
DE69426771T2
DE69426771T2 DE69426771T DE69426771T DE69426771T2 DE 69426771 T2 DE69426771 T2 DE 69426771T2 DE 69426771 T DE69426771 T DE 69426771T DE 69426771 T DE69426771 T DE 69426771T DE 69426771 T2 DE69426771 T2 DE 69426771T2
Authority
DE
Germany
Prior art keywords
syndrome
treating parkinson
dopamine
hydrogen
reincorporation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69426771T
Other languages
English (en)
Other versions
DE69426771D1 (de
Inventor
Takayuki Namiki
Toshihiro Morimoto
Kenichi Kishii
Nobuyuki Kawakatsu
Makoto Kimura
Kyoko Yamasaki
Mariko Onoda
Yuji Yoshiko
Kazunori Harada
Masayuki Yanagi
Takeshi Yamamoto
Masato Inazu
Masaki Mitani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pola Chemical Industries Inc
Original Assignee
Pola Chemical Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Chemical Industries Inc filed Critical Pola Chemical Industries Inc
Publication of DE69426771D1 publication Critical patent/DE69426771D1/de
Application granted granted Critical
Publication of DE69426771T2 publication Critical patent/DE69426771T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
DE69426771T 1993-06-25 1994-04-28 Dopaminreinkorporationshemmer zur behandlung des parkinsonschen syndroms Expired - Fee Related DE69426771T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP15556493 1993-06-25
PCT/JP1994/000728 WO1995000149A1 (fr) 1993-06-25 1994-04-28 Inhibiteur de reincorporation de dopamine

Publications (2)

Publication Number Publication Date
DE69426771D1 DE69426771D1 (de) 2001-04-05
DE69426771T2 true DE69426771T2 (de) 2001-06-13

Family

ID=15608814

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69426771T Expired - Fee Related DE69426771T2 (de) 1993-06-25 1994-04-28 Dopaminreinkorporationshemmer zur behandlung des parkinsonschen syndroms

Country Status (13)

Country Link
US (1) US5747493A (de)
EP (1) EP0706796B1 (de)
JP (1) JP3062249B2 (de)
KR (1) KR100307660B1 (de)
AT (1) ATE199318T1 (de)
AU (1) AU674955B2 (de)
CA (1) CA2163986A1 (de)
DE (1) DE69426771T2 (de)
DK (1) DK0706796T3 (de)
ES (1) ES2157258T3 (de)
GR (1) GR3035688T3 (de)
PT (1) PT706796E (de)
WO (1) WO1995000149A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3571114B2 (ja) * 1995-07-11 2004-09-29 ポーラ化成工業株式会社 麻薬拮抗剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1545094A (en) * 1976-12-14 1979-05-02 Gist Brocades Nv Piperazine derivatives
US4469695A (en) * 1980-02-25 1984-09-04 Ayerst, Mckenna & Harrison, Inc. 2-(4-Hydroxyalkyl-1-piperazinyl)-2,4,6-cycloheptatrien-1-one derivatives
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
CS271571B1 (en) * 1987-12-10 1990-10-12 Protiva Miroslav Piperazine derivatives, their salts and method of their preparation
CA1340113C (en) * 1988-05-24 1998-11-03 Magid A. Abou-Gharbia Aryl-and heteroaryl piperazinyl carboxamides having central nervous system activity
ATE81651T1 (de) * 1988-10-10 1992-11-15 Akzo Nv Substituierte aromatische verbindungen mit zentraler nervensystem-wirkung.
DE69010232T2 (de) * 1989-03-03 1994-12-01 Dainippon Pharmaceutical Co 2-(1-Piperazinyl)-4-phenylcycloalkanpyridin-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten.
JPH0747574B2 (ja) * 1989-03-03 1995-05-24 大日本製薬株式会社 ピリジン誘導体及びそれを有効成分とする向精神剤
TW205034B (de) * 1990-09-13 1993-05-01 Pola Kasei Kogyo Kk
US5089497A (en) * 1990-09-20 1992-02-18 Warner-Lambert Company Substituted piperazines as central nervous system agents
CA2067475C (en) * 1991-05-08 2000-10-10 Yasuo Oshiro Carbostyril derivatives and their use

Also Published As

Publication number Publication date
US5747493A (en) 1998-05-05
DE69426771D1 (de) 2001-04-05
KR100307660B1 (ko) 2001-12-28
WO1995000149A1 (fr) 1995-01-05
EP0706796A1 (de) 1996-04-17
AU674955B2 (en) 1997-01-16
JP3062249B2 (ja) 2000-07-10
EP0706796A4 (de) 1999-03-24
KR960702310A (ko) 1996-04-27
ES2157258T3 (es) 2001-08-16
CA2163986A1 (en) 1995-01-05
DK0706796T3 (da) 2001-03-26
AU6689194A (en) 1995-01-17
ATE199318T1 (de) 2001-03-15
PT706796E (pt) 2001-06-29
GR3035688T3 (en) 2001-07-31
EP0706796B1 (de) 2001-02-28

Similar Documents

Publication Publication Date Title
CY1108367T1 (el) Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου
ES2150489T3 (es) 1-amidinofenil-pirrolidonas, -piperidinonas, -azetinonas como inhibidores de la agregacion de plaquetas.
DK0638071T3 (da) Heterocykliske carboxylsyrederivater, der bindes til retenoidreceptorer (RAR)
HK1074794A1 (en) The use of substituted cyanopyrrolidines for treating hyperlipidemia
DE68914292D1 (de) Zusammensetzung zur Behandlung von ischämischen Störungen in Organen.
EA200000614A1 (ru) 2,3-замещенные соединения индола в качестве ингибиторов сох-2
ATE247089T1 (de) Pyridoncarbonsäurederivate oder ihre salze und diese als aktive bestandteile enthaltende medikamente
DK0453042T3 (da) Hidtil ukendte 2 9-disubstituerede 4H-pyhrido[1 2-a]pyridin-4-oner
DE69326395T2 (de) Spirooxathiolan-quinuclidin-Derivat zur Behandlung des Sjögren-Syndroms
ATE112764T1 (de) Diphenylpiperazinderivat.
FR2672801B1 (fr) Utilisation de derives de tetrahydrothienopyridine comme inhibiteurs de l'angiogenese.
PT1080081E (pt) Derivados do benzofuraxano e a sua utilizacao no tratamento da angina de peito
EP0546177A4 (de) Benzopyran derivat, seine darstellung und pharmazeutische zusammensetzung, welche dieses enthält.
FI935799A0 (fi) Arylsubstituerade heterocykliska foereningar
DE69426771D1 (de) Dopaminreinkorporationshemmer zur behandlung des parkinsonschen syndroms
DK1174131T3 (da) Anvendelse af et middel til forbedring af astrocytfunktion til behandling af Parkinsons sygdom
FI935798A0 (fi) Alkylsubstituerade heterocykliska foereningar
MY122570A (en) Benzamide derivatives and drugs containing the same
MY143862A (en) Piperidine-substituted indoles-or heteroderivatives thereof
ES2168119T3 (es) Derivados de quinoxalina para el tratamiento de tinnitus.
FI950925A (fi) Fosfono-substituoidut tetratsolijohdannaiset
DE3884878D1 (de) Uricosuretische Zusammensetzung.
BR9206978A (pt) Composição farmacêutica para inibir infecção com vírus da aids

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee